Day: February 20, 2026

By a resolution of the shareholders of Embach Ehitus OÜ, a 51%‑owned subsidiary of Nordecon AS, Ahto Aruväli has been appointed as a new member of the management board and will assume responsibility for leading Embach Ehitus OÜ’s North Estonia division. Ahto Aruväli has graduated from Tallinn University of Applied Sciences with a degree in building construction and from the University of Tartu with a degree in strategic management. Previously, Ahto has served as a member of the management board of Bildgren Ehitus OÜ, INF Infra OÜ and INF Ehitus OÜ. He holds a Level 7 professional qualification as a Chartered Civil Engineer in construction activities, design management and construction cost estimation, and is a member of the management board of the Estonian Association of Construction Entrepreneurs. Ahto Aruväli does not hold shares in...

Aktsiaselts Infortar’s subsidiary AS Tallink Grupp published today at 16:00 an announcement regarding changes to the Management Board. The full text of the announcement is provided below and is also available at the following link. Paavo Nõgene, Chairman of the Management Board of AS Tallink Grupp, has submitted an application to resign from the position of Chairman of the Management Board at his own request. Paavo Nõgene’s authority as a member of the Management Board will expire on 23 May 2026. The Supervisory Board of AS Tallink Grupp has begun the search for a new Chairman of the Management Board.Infortar operates in seven countries. The company’s main fields of activity are maritime transport, energy and real estate. Infortar owns a 68.47% share in Tallink Grupp, a 100% share in Elenger Grupp and a versatile and modern...

Appointment will strengthen board expertise in diplomacy, national security and government affairs CONROE, Texas, Feb. 20, 2026 (GLOBE NEWSWIRE) — via IBN — Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox Industries” or the “Company”) today announced the appointment of Ambassador Paula J. Dobriansky to its Board of Directors, effective Feb. 16, 2026. Ambassador Dobriansky was appointed to fill an existing board vacancy. She joins Erik Blum and Adam Falkoff, who were appointed to the board on Feb. 6, 2026. As a non-employee director, Ambassador Dobriansky will participate in the Company’s previously disclosed non-employee director compensation program, which includes an annual cash retainer, additional compensation for committee chair service, equity awards under the Company’s Stock Incentive Plan, along with pro-rata compensation...

CASTLE ROCK, Colo., Feb. 20, 2026 (GLOBE NEWSWIRE) — Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announced today that it has scheduled its fourth quarter and year-end 2025 earnings conference call for Monday, March 2, 2026, at 4:30 P.M. EST. This conference call will be available through an audio-only webcast. Please use this link here to register. Participants who choose to dial into the call in the United States or internationally, please use this link here to register. A replay of the webcast will be available after the call ends, through this link. About Riot Platforms, Inc. Riot’s (NASDAQ: RIOT) vision is to be the world’s most trusted platform for powering and building digital infrastructure. Riot’s...

NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced increasing its ownership in the common stock of Opendoor Technologies Inc., a leading digital platform for residential real estate transactions. The Company has also further reduced its short position across its cryptocurrency portfolio of Bitcoin and Ethereum and is now net long its holdings. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are...

Move delivers on the brand’s Consumer First Formula, putting products directly in the path of new consumersWarm Vanilla Sugar Body WashWarm Vanilla Sugar Body WashCOLUMBUS, Ohio, Feb. 20, 2026 (GLOBE NEWSWIRE) — Bath & Body Works today announced its official launch in Amazon’s U.S. stores, making it easier than ever for consumers to discover and shop the brand’s iconic fragrances and most loved products. Beginning today, consumers in the U.S. can explore a curated selection of Bath & Body Works’ iconic body care and home fragrances—including best sellers like Champagne Toast, A Thousand Wishes, Mahogany Teakwood, and Eucalyptus Spearmint—available in a wide range of fan-favorite forms such as fine fragrance mists, body wash, body cream, hand soap, 3-wick and single wick candles, Wallflowers, and more. This launch...

GAITHERSBURG, Md., Feb. 20, 2026 (GLOBE NEWSWIRE) — 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market leader in cutting-edge, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announced today that it will hold a virtual investor webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time. 20/20 BioLabs President and CEO Jonathan Cohen will host the webinar to discuss the company’s recent Nasdaq listing, OneTest™ for Cancer™ AI powered multi-cancer early detection (“MCED”) blood test, One Test for Longevity™ expected to be launched before the end February, ongoing initiatives, and upcoming milestones. A question-and-answer session will follow. Virtual Investor Webinar February 26, 20262:00 p.m. Eastern TimeWebcast and Presentation:https://us02web.zoom.us/webinar/register/WN_PCF8MVQOTEakBLccjP3ePg A...

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it participated in a Cell & Gene Live virtual event focused on emerging and enabling technologies designed to advance the development of innovative cell therapies. The Cell & Gene Live webinar, held on February 19, 2026, convened industry leaders and innovators to discuss approaches aimed at improving the design, development and translation of cell therapies. The Company shared perspectives on how its Gene Circuit-based approach is designed to enable enhanced precision, control, and functionality in engineered cell therapies. “We were thrilled to be invited...